Skip to content
Riskpilot
← Back to search
Sign in
Get full access
EQL Pharma AB
AB
Active
Org 5567133425
Stortorget 1, 222 23
Lund
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2006 · 19 years old
20-49 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
EQL Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
117M
233M
350M
467M
174M
2021
406M
2022
254M
2023
258M
2024
372M
2025
EBITDA
SEK millions
84M
63M
42M
21M
0M
28M
2021
38M
+36%
2022
41M
+8%
2023
31M
-24%
2024
67M
+116%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
173 944
406 049
254 333
258 167
371 910
Staff expenses
—
—
—
—
—
EBITDA
28 073
38 464
41 119
30 844
67 050
Depreciation & amort.
−17 120
—
—
—
—
EBIT
10 953
38 464
41 119
30 844
67 050
Net financials
−1 004
−2 779
−2 293
−3 948
−13 489
Profit before tax
9 949
16 005
476
1 946
16 244
Tax
−0
−0
−114
−438
−3 392
Net profit
9 949
16 005
362
1 508
12 852
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
197 432
232 739
281 781
370 283
801 956
Equity
90 462
107 324
107 879
109 652
122 698
Long-term debt
12 600
7 200
0
15 453
338 387
Short-term debt
94 370
98 215
115 402
160 178
217 871
Total debt
106 970
105 415
115 402
175 631
556 258
Financial ratios
5-year trend
EBITDA margin
18.0%
This company
15.8%
Market median
+14% vs market
2021
2025
Equity ratio
15.3%
This company
38.2%
Market median
-60% vs market
2021
2025
Return on equity
10.5%
This company
18.4%
Market median
+43% vs market
2021
2025
Net profit margin
3.5%
This company
8.1%
Market median
-57% vs market
2021
2025
Asset turnover
0.46×
This company
1.12×
Market median
-59% vs market
2021
2025
Debt / equity
5.54×
This company
0.62×
Market median
-794% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
View
PDF
More on EQL Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
